Academic Radiology
Volume 17, Issue 5 , Pages 652-657, May 2010

FDA & Digital Mammography:

Why Has FDA Required Full Field Digital Mammography Systems to Be Regulated as Potentially Dangerous Devices for More Than 10 Years?

Bioptics Inc, 3440 E Britannia Drive, Suite 150, Tucson, AZ 85706

Received 27 January 2010; accepted 27 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Mr Nields is chairman of Bioptics Inc, a company developing complementary metal-oxide semiconductor technology for applications that include full-field digital mammography.

PII: S1076-6332(10)00065-6

doi:10.1016/j.acra.2010.01.012

Academic Radiology
Volume 17, Issue 5 , Pages 652-657, May 2010